Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Sahasrabudhe, Siddhee
Pfizer Inc
101
:
The SARS-CoV-2 Mpro Inhibitor Ibuzatrelvir is a Substrate but not an Inducer nor Inhibitor of CYP3A
Siddhee Sahasrabudhe
Favorite
Schmitz, Natalie
Biogen Inc
048
:
Population Pharmacokinetic and Exposure-response Analyses of anti-BDCA2 Antibody Litifilimab Support Its Clinical Benefit for Cutaneous Lupus Erythematosus
Natalie Schmitz
Favorite
093
:
Trends in First-in-Human Trials of Intrathecal Antisense Oligonucleotide Therapies: Insights into Dose Selection, Dose Escalation & Early Clinical Development
Natalie Schmitz
Favorite
Serna Pascual, Miquel
King's College London
077
:
Advanced Waveform Analysis of ECG Signals to Characterise Cardiac Drug Safety Between Caucasian & Japanese Volunteers
Miquel Serna Pascual
Favorite
Shaik, Naveed
Pfizer Inc
027
:
A Quantitative Evaluation of the Relationship Between Hepatic Extraction Ratio & Change in Plasma Half-Life Following Modulation of CYP3A Activity
Naveed Shaik
Favorite
Shao, Jie
Janssen Research & Development LLC
166
:
Fetal & Neonatal Drug Exposure Following Nipocalimab Treatment in Pregnant Women at Risk of EOS-HDFN
Jie Shao
Favorite
Sharaby, Sherif
Novartis Pharmaceuticals Corp
162
:
Pharmacokinetics of DYP688 in Patients With Metastatic Uveal Melanoma & Other GNAQ/11 Mutant Melanomas
Sherif Sharaby
Favorite
Shen, Jinshan
Relay Therapeutics
028
:
Drug-Drug Interactions of Lirafugratinib
Jinshan Shen
Favorite
164
:
No Clinically Relevant Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Lirafugratinib
Jinshan Shen
Favorite
Shenkoya, Babajide
University of Maryland Baltimore
090
:
Pharmacokinetics of Tetrahydrocannabinol in Infants Exposed to Breastmilk from Recreational Cannabis Users
Babajide Shenkoya
Favorite
Shin, Euibeom
Univ in Buffalo School of Pharmacy & Pharmaceutical Science
011
:
Evaluation of Prompt Engineering Strategies for Pharmacokinetic Data Analysis With the ChatGPT Large Language Model
Euibeom Shin
Favorite
Smith, Dakota
Vanderbilt Univ Medical Ctr
017
:
Pharmacist Administered Parenteral Medications: A Descriptive Study of a Novel Inpatient Training Program
Dakota Smith
Favorite
Sriwijaya, Jason
University of Minnesota
084
:
Exploration of Estimated Renal Function & Gabapentin Clearance in Older Adults
Jason Sriwijaya
Favorite
Steinbronn, Claire
Merck & Co Inc
117
:
Analyzing Drug-Drug Interaction Risk Assessment Strategies for Protein Therapeutics in Inflammatory Bowel Disease: A Literature-Based Evidence Review
Claire Steinbronn
Favorite
Stevenson, Matthew
Imperial Brands
161
:
Comparison of Nicotine Pharmacokinetic & Subjective Profiles of Three Modern Oral Nicotine Products & a Snus Product
Matthew Stevenson
Favorite
Sunkaraneni, Soujanya
Syndax Pharmaceuticals, Inc.
157
:
Pharmacokinetics & Exposure-Response Analyses of Revumenib Support Dosing in a Broad Population of Patients With Relapsed/Refractory Acute Leukemias
Soujanya Sunkaraneni
Favorite
Sun, Steven
UCSD
069
:
Population Pharmacokinetics of Bictegravir in Pregnant & Postpartum Persons Living With HIV
Steven Sun
Favorite
Suram, Anitha
Blueprint Medicines Corporation
A008
:
Using Clinical Data & Physiologically-based Pharmacokinetic Modelling to Assess the Effect of Hepatic Impairment on Avapritinib Pharmacokinetics to Guide Dose Adjustment
Anitha Suram
Favorite
A008
:
Using Clinical Data & Physiologically-based Pharmacokinetic Modelling to Assess the Effect of Hepatic Impairment on Avapritinib Pharmacokinetics to Guide Dose Adjustment
Anitha Suram
Favorite
